CT image characteristics of anaplastic lymphoma kinase fusion gene positive (ALK-P) advanced stage non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Oyakawa, Takuya
Takahashi, Toshiaki
Imai, Hisao
Akamatsu, Hiroaki
Ono, Akira
Taira, Tetsuhiko
Kenmotsu, Hirotsugu
Naito, Tateaki
Murakami, Haruyasu
Endo, Masahiro
Yamamoto, Nobuyuki
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Div Diagnost Radiol, Shizuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19074
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment Sequencing in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) in Japan
    Goto, Y.
    Yamamoto, N.
    Masters, E.
    Kikkawa, H.
    Mardekian, J.
    Wiltshire, R.
    Togo, K.
    Ma, H.
    Ohe, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S878 - S879
  • [2] Ensartinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients: Updated Data
    Leal, T.
    Wakelee, H.
    Reckamp, K.
    Waqar, S.
    Patel, S.
    Blumenschein, G.
    Neal, J.
    Harrow, K.
    Holzhausen, A.
    Liang, C.
    Dukart, G.
    Horn, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S156 - S156
  • [3] Cytomorphology of Non-Small Cell Lung Carcinoma (NSCLC) with Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement
    Toll, A. D.
    Illei, P.
    Maleki, Z.
    [J]. MODERN PATHOLOGY, 2013, 26 : 104A - 104A
  • [4] Cytomorphology of Non-Small Cell Lung Carcinoma (NSCLC) with Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement
    Toll, A. D.
    Illei, P.
    Maleki, Z.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 104A - 104A
  • [5] Visual effects in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib.
    Salgia, Ravi
    Solomon, Benjamin J.
    Shaw, Alice Tsang
    Camidge, D. Ross
    Evans, Tracey L.
    Kim, Dong-Wan
    Shi, Yuankai
    Han, Ji-Youn
    De Pas, Tommaso Martino
    Ou, Sai-Hong Ignatius
    Bartlett, Cynthia Huang
    Wilner, Keith D.
    Reisman, Arlene
    Iyer, Shrividya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] VISUAL DISTURBANCES IN PATIENTS (PTS) WITH ANAPLASTIC LYMPHOMA KINASE (ALK)-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH CRIZOTINIB
    Besse, B.
    Salgia, R.
    Solomon, B.
    Shaw, A.
    Kim, D.
    Schachar, R.
    Wilner, K.
    Reisman, A.
    Bartlett, C. H.
    Iyer, S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 416 - 416
  • [7] The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
    Golding, Brandon
    Luu, Anita
    Jones, Robert
    Viloria-Petit, Alicia M.
    [J]. MOLECULAR CANCER, 2018, 17
  • [8] The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
    Brandon Golding
    Anita Luu
    Robert Jones
    Alicia M. Viloria-Petit
    [J]. Molecular Cancer, 17
  • [9] ALKConnect: An Anaplastic Lymphoma Kinase Positive (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) Patient Insights Network
    Lin, H.
    Pan, X.
    Huang, H.
    Salvatore, G.
    Clarke, S.
    West, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S617 - S617
  • [10] Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK plus ) non-small cell lung cancer (NSCLC)
    Wakelee, H.
    Reckamp, K. L.
    Leal, T. A.
    Patel, S. P.
    Blumenschein, G.
    Shum, E.
    Nieva, J.
    Oxnard, G.
    Sanborn, R. E.
    Waqar, S.
    Zeman, K.
    Dukart, G.
    Harrow, K.
    Liang, C.
    Holzhausen, A.
    Horn, L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345